Genes for the future: Discovery, ownership, access
MetadataShow full item record
Agricultural biotechnology is advancing at a rapid rate that obtaining answers to questions about gene ownership and access have become critically important. Intellectual property rights control the transfer of knowledge in the molecular biology of agricultural commodities to new technology for users and establish ownership rights to intellectual property. The views of different stakeholders were represented at the conference: consumer groups, farmers, industry, government and academia. They voiced concerns about the effects IPRs on public and private research efforts and the production and delivery of products which are essential if society is to benefit from the public and private investment. IPRs need to be examined in relation to the public good, and policies may need to be established regarding access to proprietary information in agricultural technology and public access is needed to provide researchers with genes and tools to facilitate their use.New combinations of genes in plants are a valuable resources for future civilizations because they are sources of better food, feed and fiber. However, valuation is an important consideration to sort out the proportion of value added by an inserted gene from a plant found in a developing country.While the public is not engaged with the issues of agricultural biotechnology their buy-in is critical. Current IPR policies have a negative impact on research in agricultural biotechnology, including conflict of interest issues and increased transactional costs and there are regulatory gaps.There is increased pressure on university scientists to work on short-term projects at the sacrifice of longer term fundamental research, thereby eroding our intellectual capital. Research being done at public institutions is affected by the patent process and the funding by private companies. On the other hand, patents provide an important industrial research incentives.
Agricultural biotechnology; intellectual property rights; IPR; gene transfer; genetic engineering; genum mapping; patents; research exemption; stakeholder rights,